A Case of Metastatic Adamantinoma That Responded Well to Sunitinib

Figure 1

(a) CT scan showed right hilar mass (arrow) in July 2009. (b) PET scan confirmed FDG activity of the mass. (c) Partial response after radiation therapy (October 2009). (d) Extensive disease progression (May 2011). (e) Partial response after chemotherapy (December 2011). (f) Disease progression (March 2012). (g) Reduced metabolic activity after sunitinib (August 2013). (h) Disease progression (September 2014). (i) Complete disappearance of FDG activity with central necrosis after increased dose of sunitinib (February 2015).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)